jinfukang: Clinical Trials

2 trials of jinfukang, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Unknown 1
Phase 31Unknown 1

Follow jinfukang: new trials by email Literature Review of jinfukang trials Research Report on jinfukang

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
the"Fuzheng" Therapy of TCM to Improve the Survival Quality of Early-stage NSCLC by Intervening the CTCs
JinFuKang, Cisplatin, Pemetrexed - Non-small Cell Lung Cancer(NSCLC)
Phase 1CompletedShanghai University of Traditional Chinese Medicine2182015-06-012019-09-20
Curative Study of Chinese Traditional Medicine to Treat Lung Cancer
JinFuKang, XingZaoRuanJian, pemetrexed,docetaxel,gemcitabine,paclitaxel or vinorelbine combined with carboplatin、cis-platinum or nedaplatin - Cancer
Phase 2 / Phase 3UnknownShanghai University of Traditional Chinese Medicine1202014-09-012017-10-10

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)  ·  Neoplasms (1)  ·  Neoplastic Cells, Circulating (1)

Sponsors

Shanghai University of Traditional Chinese Medicine (2)